After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.
Differential expression of hepatocyte growth factor, transforming growth factor-α and transforming growth factor-β1 messenger RNAs in two experimental models of liver cell proliferation
✍ Scribed by Masaaki Masuhara; Sikandar L. Katyal; Toshikazu Nakamura; Hisashi Shinozuka
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 1021 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Hepatocyte growth factor, a potent hepatocyte mitogen in vitro, appears to trigger hepatocyte regeneration after partial hepatectomy and after acute liver cell netcrosis. Transforming growth factor-a and transforming growth factor+, may also be involved in the control of liver regeneration. In this study we assessed possible roles of hepatocyte growth factor, transforming growth factor-a and transforming growth facto-, on liver cell proliferation in uim, using a made1 of choline deficiency that is associated with liver cell necrosis and a model of a hypolipidemic agent (4-chloro-6-(2,3 xylidino)-2-pyrimidinylthio (N-@-hyhxyethyl) acetamide) without liver necrosis. Male F344 rats were fed a choline-deficient diet or 0.16% 4-chloro-6-(2,3 xylidino)-2-pyrimidinylthio (N-phydmxyethyl) acetamide diet for 6 and 4 wk, respectively. Rats were killed periodically, and the expression of hepatocyte growth factor messenger RNA in the liver, lung and kidney was determined by Northern-blot analysis. The levels of transforming growth factor-a and transforming growth factor-& messenger RNAs in the liver were also determined. Feeding a choline-deficient diet for 1 to 6 wk led to gradual increases in the levels of hepatocyte growth factor, transforming growth factor-a and transforming growth factor+, messenger RNAs in the liver. Feeding a 4-chloro-6-(2,3 xylidino)-2-pyrimidinylthio CN-B-hydmxyethyl) acetamide diet for 3 days and 2 wk induced marked enhancement of liver cell proliferation as judged by hepatocyte S-bromo-2-deoxyuridine incorporation. In contrast to the choline-deficient diet-induced liver cell proliferation, 4chloro-6-(2,3 sylidino)-2-pyrimidinylthio (N-@hydroxyethyl) acetamide-induced liver cell proliferation was aesociated with decreased levels of hepatocyte growth factor and transforming growth factor+, messenger RNAs. Feeding of a cholinedeficient diet or 4-chloro-6-(2,3 xylidino)-2-pyrimi-
📜 SIMILAR VOLUMES
We have previously shown that transforming growth factor-b1 (TGF-b1) enhances the epidermal growth factor-(EGF) and transforming growth factor-a (TGF-a)stimulated motility of rat hepatocytes in an extracellular matrix (ECM)-dependent fashion (Stolz and Michalopoulos, 1997, J. Cell. Physiol., 170:57-
Hepatocyte growth factor and transforming growth factor-a are two well-known hepatomitogens for primary hepatocyte cultures. Here we report that these two growth factors also stimulate in uiuo DNA syntheses in normal, unoperated, adult rat liver after 24-hr continuous intraportal infusion. As determ
## Abstract ## Objectives/Hypothesis: To investigate the expression of genes coding transforming growth factor (TGF)‐β1, hepatocyte growth factor (HGF), and c‐Met, its membrane‐spanning tyrosine kinase receptor, during the inflammatory, proliferative, and remodeling phases of wound healing in the
We have previously shown that rat liver epithelial cells (RLEC) transfected with and constitutively expressing transforming growth factor-α (TGF-α) have an enhanced mitogenic response to hepatocyte growth factor (HGF). In the study reported here, we examined tumor clones derived from the TGF-α trans
Antibodies to epidermal-growth-factor receptor (EGF) and transforming growth factor-a (TGVa) were used to determine the role of endogenous TGF-a in the growth of 2 human colon-carcinoma cell lines. Both the GEO and HCT I 16 coloncarcinoma cell lines secrete similar levels of TGF-a and have similar n